CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 192 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,019,052 | +34.8% | 87,173 | +55.0% | 0.18% | +41.2% |
| Q2 2023 | $755,798 | -18.9% | 56,235 | 0.0% | 0.13% | -20.1% |
| Q1 2023 | $932,376 | -31.7% | 56,235 | -23.4% | 0.16% | -30.5% |
| Q4 2022 | $1,365,575 | +28.3% | 73,418 | -11.5% | 0.24% | +17.4% |
| Q3 2022 | $1,064,000 | +1.1% | 82,935 | -44.7% | 0.20% | +9.8% |
| Q2 2022 | $1,052,000 | -13.9% | 150,059 | +1.8% | 0.18% | +33.6% |
| Q1 2022 | $1,222,000 | +14.1% | 147,416 | -6.8% | 0.14% | -11.6% |
| Q4 2021 | $1,071,000 | -6.5% | 158,202 | -26.8% | 0.16% | +18.3% |
| Q3 2021 | $1,146,000 | – | 216,144 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |